Additionally, pathogenic/likely pathogenic germline and oncogenic/likely oncogenic somatic mutation calls were made for the BRCA1, BRCA2, and PALB2 genes and were considered indicators of homologous recombination deficiency (HRD). The gene discussed is BRCA1; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.